Genesys, a leading developer of AI-driven call center software, has postponed its highly anticipated initial public offering (IPO) due to increased stock market volatility, according to The Information. Originally set for April or May, the IPO is now expected to take place later in 2025.
The AI firm had confidentially filed for an IPO in late 2024, aiming to capitalize on surging market interest in artificial intelligence. Reports suggested Genesys could raise up to $2 billion through the offering. However, given the unpredictable market conditions, the company has opted to delay its debut.
Backed by major investors such as Salesforce (NYSE: CRM), Zoom Video Communications (NASDAQ: ZM), and BlackRock (NYSE: BLK), Genesys remains a key player in AI-powered customer service solutions. The company was acquired by private equity firm Permira Holdings in 2012 for approximately $1.5 billion.
Despite the delay, Genesys is expected to proceed with its IPO when market conditions stabilize, aligning with the growing demand for AI in enterprise solutions.


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



